Phase IV Clinical Study of Recombinant Mycobacterium Tuberculosis Fusion Protein

NCT05746611 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

7500

Enrollment

INDUSTRY

Sponsor class

Conditions

Latent Tuberculosis Infection

Interventions

BIOLOGICAL: Recombinant Mycobacterium tuberculosis fusion protein for injection
BIOLOGICAL: TB-PPD was injected

Sponsor

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.